Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CCAP
CCAP logo

CCAP Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Crescent Capital BDC Inc (CCAP) Today? Analysis, Price Targets, and 2026 Outlook.

No data

No data

No data

No data

Growth

Profitability

Efficiency

Wall Street analysts forecast CCAP stock price to rise
5 Analyst Rating
Wall Street analysts forecast CCAP stock price to rise
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 11.000
sliders
Low
14
Averages
16
High
19
Current: 11.000
sliders
Low
14
Averages
16
High
19
Keefe Bruyette
Outperform
to
NULL
downgrade
$15 -> $13
AI Analysis
2026-06-16
Reason
Keefe Bruyette
Price Target
$15 -> $13
AI Analysis
2026-06-16
downgrade
Outperform
to
NULL
Reason
Keefe Bruyette lowered the firm's price target on Crescent Capital BDC to $13 from $15 and keeps an Outperform rating on the shares.
B. Riley
B. Riley
Neutral
maintain
$13.50
2026-05-15
Reason
B. Riley
B. Riley
Price Target
$13.50
2026-05-15
maintain
Neutral
Reason
B. Riley keeps a Neutral rating on Crescent Capital BDC with a $13.50 price target following the "mixed" Q1 report. The biggest positive of the quarter is Crescent management permanently reducing the base management fee to 1.00% from 1.25% and the incentive fee to 15.0% from 17.5%, the analyst tells investors in a research note. The company "right-sized" the base dividend to 34c per share, providing needed support for forward net interest income coverage, the analyst tells investors in a research note. Riley believes the "shareholder friendly management fee change" brings Crescent back to the best fee structure among the peer group. However, the firm reduced estimates to reflect the company's near-term refinancings and portfolio yield compression.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CCAP
Unlock Now

People Also Watch